| Initial public offering of up to [*] equity shares of face value of Rs. 2 each ("Equity Shares") of Shiva Pharmachem Limited ("The Company" or "Issuer") for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) ("Offer price") aggregating up to
Rs. 900.00 crores ("Offer") through an offer for sale of up to [*] equity shares aggregating up to Rs. 383.00 crores Vishal Rakesh Agrawal, up to [*] equity shares aggregating up to Rs. 383.00 crores by Rahul Rakesh Agrawal (collectively, "Promoter Selling Shareholders") and up to [*] equity shares aggregating up to Rs. 134.00 crores by Geetganga Investment Private Limited ("Promoter Group Selling Shareholder") (the promoter selling shareholders and promoter group selling shareholder, collectively referred to as "Selling Shareholders" and such offer for sale by the selling shareholders, "Offer for Sale"). The offer shall constitute [*] % of the post-offer paid-up equity share capital of the company.
The price band and the minimum bid lot will be decided by the company.
|